It would be nice if proponents of “medical” marijuana would drop the pretense and admit their endgame: recreational weed for sale in Pennsylvania.

All through the weed debates and state hearings, we were told how it was crucial — an act of humanity, really — to legalize “medical” marijuana, as if modern science had overlooked the miraculous health benefits of pot.

As PhillyNORML, the region’s premier weed proponent, puts it on its website: “Our aim is to ensure passage of legislation that genuinely helps people suffering from a variety of maladies, including seizure conditions, cancer, HIV, PTSD, and chronic pain.”

What, weed doesn’t cure cancer and the common cold, too?

They also made it clear — only because it was repeated 10,000 times — that under Pennsylvania’s “medical” marijuana law, leafy “smokable” forms of the plant would not be sold. Only cannabis oils, pills, ointments and “tinctures.”

Now we learn that there is a “loophole” in the state medical marijuana law that, in fact, allows good old bud to be sold from “dispensaries” — and this major change does not require our lawmakers to vote on it.

The law has a provision in which an advisory panel makes recommendations to the state Department of Health on what forms marijuana can be sold in the commonwealth.

State Sen. Daylin Leach, D-Montgomery, prime mover behind Pennsylvania’s “medical” marijuana bill, said it’s basically a done deal.

Leach, speaking at the World Medical Cannabis Expo in Pittsburgh in April, said the panel will recommend that Pennsylvania sell leaf, “because we’re appointing people to do that…. They will recommend that at latest by April 17 (2018), which means when dispensaries open (next year), it is likely that they will have whole plant on their shelves from day one.”

Leach, for all his eccentricities as a public official, is one of

Read More Here...